Recommandations dans le traitement des dyslipidémies chez les patients diabétiques: un choix raisonné ?

Descamps, Olivier
(2016) 13e Congrès UCL d’Endocrino-Diabétologie — Location: (Belgium) Bruxelles (19.March.2016)

Files

2016_Descamps_LM_1353_107-119.pdf
  • Restricted Access
  • Adobe PDF
  • 1.41 MB
No access

Details

Authors
  • Descamps, OlivierUCLouvain
    Author
Abstract
(en) [Recommendations for management of dyslipidemia in diabetic patients: a well-reasoned choice?] In diabetic patients, lipid-lowering drug therapy is almost always necessary, even when the lipid profile is seemingly unremarkable. This treatment is primarily aimed at reaching the target LDL cholesterol level (<70 mg/dL or <100 mg/dL, depending on prior cardiac or renal diseases, age, or concomitant risk factors) by prescribing a statin, with or without ezetimibe. Thereafter, adding a fibrate or including omega-3 fatty acid supplementation should be considered in patients whose triglyceride levels remain high, so as to target non-HDL cholesterol (<100 mg/dL or <130 mg/dL, depending on age or concomitant risk factors).
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Descamps, O. (2016). Recommandations dans le traitement des dyslipidémies chez les patients diabétiques: un choix raisonné ? Louvain médical, 135(3), 107-119. https://hdl.handle.net/2078.5/184852 (Original work published 2016)